Navigation Links
Qualia Clinical Services Chooses ALPHADAS(R) for Phase I Clinical Trials

LONDON, October 21 /PRNewswire/ -- Qualia Clinical Services, a highly regarded division of Holmes Biopharma, selects ALPHADAS(R), Logos Technologies electronic data capture (EDC) system to streamline and automate clinical trials in its Phase I clinical facility in Omaha, Nebraska.

"Automating our recently expanded Phase I facility with ALPHADAS will enable us to provide our Pharma and Biotech sponsors with top quality, real time access to critical data while conducting state-of-the-art clinical trials." - Azhar Kalim, COO of Qualia Clinical Services, Inc.

"We are committed to helping our clients accelerate their time-to-market. We decided to re-evaluate the market because our previous EDC vendor was not meeting our business needs. We chose industry leading ALPHADAS to achieve our operational goals." - Dr. Sohail Khattak, CEO/President and CSO.

Logos Technologies has been providing early phase EDC and clinical site automation tools to the pharmaceutical industry for over 12 years. "We are delighted to welcome Qualia Clinical Services as a new client and value this opportunity to facilitate its operational goals," said Giles Wilson, BEng, co-founder of Logos Technologies. "The partnership will help our mission to become the world's leading early phase EDC and clinical trial automation company, assisting organizations to reduce the development time of life-saving and life-enhancing drugs."

The rapid success of Qualia's Phase I facility, which opened in the fall of 2006, necessitated the recent addition of 10,000 square feet. The clinic now boasts a total of 33,000 square feet, a bed capacity of over 160 beds and more than 150 professional staff. Additionally, administrative, operational and recreational areas were completely redesigned to better serve clients and study participants. Qualia Clinical Services, is changing lives for the better by providing its partners in the clinical research industry the full capabilities to complete early and late phase clinical trials. A full service contract research organization, Qualia has state-of-the-art clinical operations in Omaha, Nebraska , Toronto, Canada and Kiev, Ukraine. More information about Qualia can be obtained through its website at

Logos Technologies is a leading provider of world-class integrated clinical trial solutions to the world's pharmaceutical, biotechnology and clinical research organisations. ALPHADAS is a clinical study management and fully mobile early Phase proactive EDC system that has been designed for real time eSource data collection. The system provides time based data entry at the bedside, collection and integration of laboratory data, images and scans and Bar-coded labeling to track samples from draw to dispatch. Logos Technologies established and proven product ALPHADAS sets the standard in collecting early Phase clinical trial data. ALPHADAS is fully compliant with industry standards and guidelines including FDA 21 CFR Part 11. More information about Logos Technologies can be obtained through its website at

For more information contact Angela King, Logos Technologies Ltd, +44(0)8707-478900,

SOURCE Logos Technologies
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. Clinical Update - Debio 9902 SR (ZT-1) for Alzheimer Patients Debiopharm Starts Tablet Formulations Bridging Study under IND
2. Raptor Pharmaceuticals Announces Phase 2a Clinical Trial Initiation in Non-Alcoholic Steatohepatitis (NASH)
3. Multi-Centre European Clinical Trial Shows Advanced Dysplasia and Early Cancer of Esophagus Cured With Combined Endoscopic Resection and Radiofrequency Ablation With HALO Ablation System
4. CeNeRx BioPharma Initiates Phase II Clinical Trial of Its Novel Antidepressant Agent Tyrima(TM)
5. BioMarin Announces Positive Results From Phase 2A Clinical Study of 6R-BH4 in Sickle Cell Disease
6. First Town Hall Meeting on Inequities in Clinical Trials to Take Place at the Harlem Hospital Center on October 20
7. Perceptive Informatics Improves Clinical Trial Management With Enhanced TrialWorks(R) Solution
8. Insmed Initiates Clinical Study for Follow-on Biologic Version of Neulasta(R)
9. Surveyed Oncologists Say That the Most Promising Targeted Therapy in Adjuvant Clinical Trials is Avastin for the Treatment of Early-Stage Colorectal Cancer
10. Paratek to Present Clinical Data in Late Breaker Presentation at the 48th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy
11. XTENT Announces Clinical Trial Data to be Presented at Annual Meeting of Transcatheter Cardiovascular Therapeutics Next Week
Post Your Comments:
(Date:11/30/2015)... -- Varian Medical Systems (NYSE: VAR ) has signed a ... Hospitals Group, the largest hospital chain in India ... in the country. The MoU was signed by Dr. K. ... Kakkar , Varian,s India managing director, in ... , Varian intends to deploy its Access to Care program by ...
(Date:11/30/2015)... , Nov. 30, 2015  Novartis will demonstrate ... the 57 th American Society of Hematology (ASH) ... and myelomas as well as supportive care, including key ... to personalized cell therapies. The ASH Annual Meeting will ... . Novartis Oncology . "We will ...
(Date:11/30/2015)... KIRKLAND, Wash. , Nov. 30, 2015 /PRNewswire/ ... of Post-Processing services, is pleased to announce a ... of medical imaging services. Building on its ISO-9001:2008 ... adopted and implemented comprehensive Core Lab protocols and ... wide variety of research activities.  Their Core Lab ...
Breaking Medicine Technology:
(Date:11/30/2015)... ... November 30, 2015 , ... The Foundation for Breast and ... prevention—is joining forces with the award-winning creator and writer of Downton Abbey Julian ... 2015 at the Union League of Philadelphia. , The benefit, titled “An ...
(Date:11/30/2015)... ... , ... The American Society for Clinical Pathology (ASCP) announced today that it ... Nov. 30, ASCP shared its “Give a minute. Get tested. Find a cure.” icon ... of getting tested for HIV. , ASCP has asked members to replace their Facebook, ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... their exclusive channel partner for the Nutraceutical Specialties products into oral solid dosage ... effective immediately. , “We are pleased to announce our expanded distribution agreement ...
(Date:11/30/2015)... , ... November 30, 2015 , ... ... magazine, quoted Michael Hansen, Ph.D., a senior scientist at Consumer Reports as supporting ... so for a child’s exposure limits. , The original Nov 2015 CR story ...
(Date:11/30/2015)... , ... November 30, 2015 , ... ... for the last 15 years, announced today that Michigan-based Family Health Center (FHC) ... care for over 45 years, FHC was awarded the largest Affordable Care Act ...
Breaking Medicine News(10 mins):